Australian Study Links Fertility Treatments to Higher ADHD Medication Use in Children
A recent Australian study tracking children from birth to age 16 found that those conceived through medically assisted reproduction (MAR) are more likely to use healthcare services and medications for attention deficit hyperactivity disorder (ADHD) compared to children conceived naturally. The research, published in the American Journal of Obstetrics & Gynecology, analyzed 4,789 single children born in 2003-2004, including 246 conceived via MAR, which encompasses IVF, intrauterine insemination, ovulation induction, and other fertility treatments.
The study linked longitudinal data from the Growing Up in Australia project with Medicare records to assess outpatient healthcare usage and prescription medication patterns. Children born after fertility treatments had consistently higher outpatient healthcare use, especially at ages two to five. Most notably, these children were 2.4 to 3.2 times more likely to receive ADHD medications between ages six and 15. For example, at ages 6-7, 3.62% of MAR children used ADHD drugs versus 1.26% of naturally conceived children; at ages 14-15, the rates were 6.94% versus 3.03%. Increased use of mental health medications was also observed at ages four to seven but not at older ages.
The researchers controlled for socioeconomic factors, parental age, birth weight, gestational age, cesarean delivery, and maternal health conditions during pregnancy, yet the differences remained significant. They caution that the study cannot definitively attribute these findings to fertility treatments themselves, as underlying parental infertility or genetic and environmental factors may contribute. Additionally, the study could not differentiate between types of fertility treatments or fully account for parental mental health conditions such as ADHD.
Given that fertility treatments have evolved since 2003-2004, the authors warn against directly extrapolating these results to children born from current procedures. They emphasize that the findings do not imply that all children conceived via fertility treatments are at higher risk for ADHD but suggest that this group may have distinct healthcare needs. The study highlights the importance of continued research and monitoring to enable earlier identification and support for potential developmental issues in this population.
